The Patent Finder

Methods of Treating Cancer Using Antibodies and Molecules That Immunospecifically Bind to BTN1A1

Stcube & Co., Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 10,875,920Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
In force
 · High confidence
Board of Regents, the University of Texas SystemIn force
High confidence
US 11,970,534Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
In force
 · High confidence
Board of Regents, the University of Texas SystemIn force
High confidence
US 11,542,331Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS
In force
 · High confidence
Stcube & Co., Inc.In force
High confidence
US 12,215,151Methods of Treating Cancer Using Antibodies and Molecules That Immunospecifically Bind to BTN1A1
In force
 · High confidence
Stcube & Co., Inc.In force
High confidence
Application 15/575,325Screening Methods for Targets for Cancer Therapy
Abandoned
Abandoned Jul 7, 2025
Board of Regents, the University of Texas SystemAbandonedAbandoned Jul 7, 2025
Application 16/618,042Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Abandoned
Abandoned Nov 15, 2024
Stcube & Co., Inc.AbandonedAbandoned Nov 15, 2024
Application 18/066,879Methods of Treating Cancer Using Antibodies and Molecules That Bind to BTN1A1 or BTN1A1-LIGANDS
Pending
Not granted
Stcube & Co., Inc.PendingNot granted
Application 18/625,891Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Pending
Not granted
Board of Regents, the University of Texas SystemPendingNot granted
Application 18/763,821Antibodies and Molecules That Immunospecifically Bind to BTN1A1 and the Therapeutic Uses Thereof
Pending
Not granted
Stcube & Co., Inc.PendingNot granted
Application 18/847,179BTN1A1 Binding Proteins and Methods of Use Thereof
Pending
Not granted
Stcube & Co., Inc.PendingNot granted
2 more patents in this group · Pro
10 of 12 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 12.
Upgrade to Pro
2 of these are in force and held by Stcube & Co., Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited